
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MiR‐142‐3p regulates synaptopathy‐driven disease progression in multiple sclerosis
Francesca De Vito, Alessandra Musella, Diego Fresegna, et al.
Neuropathology and Applied Neurobiology (2021) Vol. 48, Iss. 2
Open Access | Times Cited: 27
Francesca De Vito, Alessandra Musella, Diego Fresegna, et al.
Neuropathology and Applied Neurobiology (2021) Vol. 48, Iss. 2
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Multiple Sclerosis: Roles of miRNA, lcnRNA, and circRNA and Their Implications in Cellular Pathways
Giovanni Luca Cipriano, Giovanni Schepici, Emanuela Mazzon, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2255-2255
Open Access | Times Cited: 18
Giovanni Luca Cipriano, Giovanni Schepici, Emanuela Mazzon, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2255-2255
Open Access | Times Cited: 18
Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease
Lawrence Steinman, Roberto Patarca, William A. Haseltine
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 2
Open Access | Times Cited: 22
Lawrence Steinman, Roberto Patarca, William A. Haseltine
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 2
Open Access | Times Cited: 22
Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers
Mina Mohammadinasr, Soheila Montazersaheb, Ommoleila Molavi, et al.
NeuroMolecular Medicine (2023) Vol. 25, Iss. 3, pp. 402-414
Closed Access | Times Cited: 20
Mina Mohammadinasr, Soheila Montazersaheb, Ommoleila Molavi, et al.
NeuroMolecular Medicine (2023) Vol. 25, Iss. 3, pp. 402-414
Closed Access | Times Cited: 20
Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration
Reiner Kunze, Silvia Fischer, Hugo H. Marti, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 15
Reiner Kunze, Silvia Fischer, Hugo H. Marti, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 15
Targeted miRNA Delivery in Epilepsy: Mechanisms, Advances, and Therapeutic Potential
Mukul Shyam, Oveyaa Bm, Prathap Srirangan, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Mukul Shyam, Oveyaa Bm, Prathap Srirangan, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Expression Patterns of miRNA in the Experimental Autoimmune Encephalomyelitis (EAE)/MS Model Treated With Oenothera biennis Oil
Huri Dedeakayoğulları, Zozan Güleken, Şahabettin Selek, et al.
Acta Neurologica Scandinavica (2025) Vol. 2025, Iss. 1
Open Access
Huri Dedeakayoğulları, Zozan Güleken, Şahabettin Selek, et al.
Acta Neurologica Scandinavica (2025) Vol. 2025, Iss. 1
Open Access
Interleukin-9 protects from microglia- and TNF-mediated synaptotoxicity in experimental multiple sclerosis
Livia Guadalupi, Valentina Vanni, Sara Balletta, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Livia Guadalupi, Valentina Vanni, Sara Balletta, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
MiRNA-based therapeutic potential in multiple sclerosis
Ana Zabalza, Agustín Pappolla, Manuel Comabella, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Ana Zabalza, Agustín Pappolla, Manuel Comabella, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
An innovative nanoformulation utilizing tumor microenvironment-responsive PEG-polyglutamic coating and dynamic charge adjustment for specific targeting of ER stress inducer, microRNA, and immunoadjuvant in pancreatic cancer: In vitro investigations
Ching-Yao Li, Tsui‐Fen Chou, Yu‐Li Lo
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127905-127905
Closed Access | Times Cited: 7
Ching-Yao Li, Tsui‐Fen Chou, Yu‐Li Lo
International Journal of Biological Macromolecules (2023) Vol. 254, pp. 127905-127905
Closed Access | Times Cited: 7
Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis
Patrizia LoPresti
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1077-1077
Open Access | Times Cited: 11
Patrizia LoPresti
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1077-1077
Open Access | Times Cited: 11
Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature
Sara Redenšek, David Vogrinc, Katja Goričar, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 6
Sara Redenšek, David Vogrinc, Katja Goričar, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 6
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis
Francesca De Vito, Sara Balletta, Silvia Caioli, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 12, pp. 2567-2582
Open Access | Times Cited: 5
Francesca De Vito, Sara Balletta, Silvia Caioli, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 12, pp. 2567-2582
Open Access | Times Cited: 5
Potential nanocarrier-mediated miRNA-based therapy approaches for multiple sclerosis
K. Trideva Sastri, N. Vishal Gupta, Anbarasu Kannan, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 11, pp. 103357-103357
Closed Access | Times Cited: 7
K. Trideva Sastri, N. Vishal Gupta, Anbarasu Kannan, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 11, pp. 103357-103357
Closed Access | Times Cited: 7
Interaction between miR-142-3p and BDNF Val/Met Polymorphism Regulates Multiple Sclerosis Severity
Ettore Dolcetti, Alessandra Musella, Sara Balletta, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5253-5253
Open Access | Times Cited: 1
Ettore Dolcetti, Alessandra Musella, Sara Balletta, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5253-5253
Open Access | Times Cited: 1
Enhancing brain health: Swimming-induced BDNF release and epigenetic influence in MS female mouse models
Soheila Banasadegh, Shahnaz Shahrbanian, Reza Gharakhanlou, et al.
Journal of Ethnicity in Substance Abuse (2024), pp. 1-17
Closed Access | Times Cited: 1
Soheila Banasadegh, Shahnaz Shahrbanian, Reza Gharakhanlou, et al.
Journal of Ethnicity in Substance Abuse (2024), pp. 1-17
Closed Access | Times Cited: 1
microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate
María Inmaculada Domínguez‐Mozo, Ignacio Casanova, Laura De Torres, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
María Inmaculada Domínguez‐Mozo, Ignacio Casanova, Laura De Torres, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Novel CSF Biomarkers Tracking Autoimmune Inflammatory and Neurodegenerative Aspects of CNS Diseases
Elisabeth Kapaki, Aigli G. Vakrakou, Fotini Boufidou
Diagnostics (2022) Vol. 13, Iss. 1, pp. 73-73
Open Access | Times Cited: 6
Elisabeth Kapaki, Aigli G. Vakrakou, Fotini Boufidou
Diagnostics (2022) Vol. 13, Iss. 1, pp. 73-73
Open Access | Times Cited: 6
Free circulating miRNA as a potential diagnostic marker in multiple sclerosis (review)
М. А. Omarova, М. С. Козин, А. N. Boyko
Neurology neuropsychiatry Psychosomatics (2022) Vol. 14, Iss. 1S, pp. 29-33
Open Access | Times Cited: 3
М. А. Omarova, М. С. Козин, А. N. Boyko
Neurology neuropsychiatry Psychosomatics (2022) Vol. 14, Iss. 1S, pp. 29-33
Open Access | Times Cited: 3
miRNAs: Targets to Investigate Herpesvirus Infection Associated with Neurological Disorders
Vanessa Cristine de Souza Carneiro, Luciane Almeida Amado Leon, Vanessa Salete de Paula
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15876-15876
Open Access | Times Cited: 1
Vanessa Cristine de Souza Carneiro, Luciane Almeida Amado Leon, Vanessa Salete de Paula
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15876-15876
Open Access | Times Cited: 1
Regulatory role of the miR-142-3p/CDC25C axis in modulating autophagy in non-small cell lung cancer
Jing Meng, Zongchang Song, Shuxian Cong, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 3, pp. 552-572
Open Access
Jing Meng, Zongchang Song, Shuxian Cong, et al.
Translational Lung Cancer Research (2024) Vol. 13, Iss. 3, pp. 552-572
Open Access
Hederagenol improves multiple sclerosis by modulating Th17 cell differentiation
Dongsheng Guan, Yingxia Li, Xu Zhao, et al.
IUBMB Life (2024)
Closed Access
Dongsheng Guan, Yingxia Li, Xu Zhao, et al.
IUBMB Life (2024)
Closed Access
[Expression of miR-142 and its relationship with Th17/Treg imbalance in children with autoimmune thyroid disease].
Ping Luo, Yan-Mei Xin, Qulian Guo, et al.
PubMed (2024) Vol. 26, Iss. 6, pp. 605-610
Closed Access
Ping Luo, Yan-Mei Xin, Qulian Guo, et al.
PubMed (2024) Vol. 26, Iss. 6, pp. 605-610
Closed Access
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis
Luana Gilio, Diego Fresegna, Mario Stampanoni Bassi, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access
Luana Gilio, Diego Fresegna, Mario Stampanoni Bassi, et al.
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access
ADAR1-regulated miR-142-3p/RIG-I axis suppresses antitumor immunity in nasopharyngeal carcinoma
Haoyuan Xu, Wanpeng Li, Kai Xue, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 116-129
Open Access
Haoyuan Xu, Wanpeng Li, Kai Xue, et al.
Non-coding RNA Research (2024) Vol. 10, pp. 116-129
Open Access